Antibody against CLDN6 and use thereof

TW202639597APending Publication Date: 2026-10-01SHANGHAI QILU PHARMACEUTICAL RESEARCH & DEVELOPMENT CENTRE LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114148511
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-11
Filing Date
2025-12-10
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078764_001
    Figure TWG2TA001078764_001
  • Figure TWG2TA001078764_002
    Figure TWG2TA001078764_002
  • Figure TWG2TA001078764_003
    Figure TWG2TA001078764_003
Patent Text Reader

Abstract

The present invention provides anti-CLDN6 antibodies or antigen-binding fragments thereof, pharmaceutical compositions containing anti-CLDN6 antibodies or antigen-binding fragments thereof, and the use of anti-CLDN6 antibodies or antigen-binding fragments thereof in the treatment and / or prevention of tumors, thereby providing a novel treatment approach for tumors.
Need to check novelty before this filing date? Find Prior Art